Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-09-28 2024-03-15 205480
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-OXYCODONE CR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-06 208382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-06 2024-03-15 209286
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-26 212362
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-01 2024-02-02 212368
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-05 212392
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-08 2024-01-19 212969

Showing 2941 to 2960 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-01-03 2019-01-03 71112
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436

Showing 301 to 320 of 356